Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PDS Planning Inc raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,426 shares of the biopharmaceutical company’s stock after buying an additional 182 shares during […]
Sage Mountain Advisors LLC grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,717 shares of the biopharmaceutical company’s stock after purchasing an additional 345 shares during the quarter. […]
Commerzbank Aktiengesellschaft FI bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,656 shares of the biopharmaceutical company’s stock, valued at approximately $378,000. Several other institutional investors and hedge funds have […]
Kornitzer Capital Management Inc. KS decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 375,325 shares of the biopharmaceutical company’s stock after selling 1,170 shares during the quarter. […]
Abrdn plc grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 89.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,764,107 shares of the biopharmaceutical company’s stock after acquiring an additional 1,772,887 shares during the quarter. Gilead Sciences […]